Lewis Gryziewicz - Macrocure Vice President - Regulatory Affairs

President

Dr. Lewis Gryziewicz is Vice President Regulatory Affairs of Macrocure Ltd. Prior to joining Macrocure, Dr. Gryziewicz spent 16 years at Allergan, 10 years at Johnson Johnson and 3 years at BristolMyers Squib. At Allergan, Dr. Gryziewicz held seniorlevel positions within Regulatory Affairs, most recently as Global Regulatory Liaison for Ophthalmology, where he was responsible for the submission and approval of global marketing applications, liaising with global regulatory agencies, and regulatory strategy, which led to product approvals, including US and European Union approvals of Ozurdex and Combigan and approval in the US and Japan for Alphagan P and Lumigan, among others. During his tenure at Johnson Johnson, Dr. Gryziewicz also held positions in Regulatory Affairs and was responsible for the approval of the acne indication for Ortho TriCyclen and the removal of the black box warning for Renova since 2015.
Tenure 9 years
Professional MarksMBA
Phone972 3 923 5556
Webhttp://www.macrocure.com
Gryziewicz holds a PharmD from the University of Colorado, a BS in Pharmacy from the Philadelphia College of Pharmacy and Science, and an MBA from Fairleigh Dickinson University.

Macrocure Management Efficiency

The company has return on total asset (ROA) of (0.193) % which means that it has lost $0.193 on every $100 spent on assets. This is way below average. Macrocure's management efficiency ratios could be used to measure how well Macrocure manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

PRESIDENT Age

Steve HightowerPresidio Property Trust
56
Suzanne BodaAmerican Airlines Group
N/A
William RisAmerican Airlines Group
N/A
Stephen MackeyMGIC Investment Corp
57
Paula MaggioMGIC Investment Corp
55
Andrew NocellaAmerican Airlines Group
45
Kurt StacheAmerican Airlines Group
N/A
Gregory ChiMGIC Investment Corp
57
Hector AdlerAmerican Airlines Group
N/A
James HughesMGIC Investment Corp
61
Domas GirtaviciusAmerican Airlines Group
28
Danielle KirganAmerican Airlines Group
N/A
Salvatore MiosiMGIC Investment Corp
56
Thomas LauerFidus Investment Corp
56
Robert CandelmoMGIC Investment Corp
60
Alison TaylorAmerican Airlines Group
N/A
Nathaniel ColsonMGIC Investment Corp
40
Tomas SidlauskasAmerican Airlines Group
29
Elise EberweinAmerican Airlines Group
52
Scott KirbyAmerican Airlines Group
46
Macrocure Ltd., a biotechnology company, focuses on developing, manufacturing, and commercializing novel cell therapy solutions for the treatment of chronic and other hardtoheal wounds in Israel. Macrocure (MCUR) is traded on NASDAQ Exchange in USA and employs 13 people.

Management Performance

Macrocure Leadership Team

Elected by the shareholders, the Macrocure's board of directors comprises two types of representatives: Macrocure inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Macrocure. The board's role is to monitor Macrocure's management team and ensure that shareholders' interests are well served. Macrocure's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Macrocure's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lewis Gryziewicz, Vice President - Regulatory Affairs
Danna Moran, Marketing and Sales Manager
Alan Smith, Head - North American Operations
Nissim Mashiach, Pres and CEO
Ramesh Tharuvai, VP of Operations
David Ami, Chairman of the Board and Co-Founder
Mark Page, CFO

Macrocure Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Macrocure a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Macrocure in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Macrocure's short interest history, or implied volatility extrapolated from Macrocure options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Consideration for investing in Macrocure Stock

If you are still planning to invest in Macrocure check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Macrocure's history and understand the potential risks before investing.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets